148 related articles for article (PubMed ID: 35842788)
61. Absence of KHDC3L mutations in Chinese patients with recurrent and sporadic hydatidiform moles.
Zhao W; Muhetaer A; Luo T; Zhou W; Qi C; Chen X; Zhang X; Zhang Z; Dery C; Slim R; Qian J
Cancer Genet; 2013; 206(9-10):327-9. PubMed ID: 24215781
[TBL] [Abstract][Full Text] [Related]
62. Genetics of gestational trophoblastic disease.
Fisher RA; Maher GJ
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():29-41. PubMed ID: 33685819
[TBL] [Abstract][Full Text] [Related]
63. A Novel Genetic Mutation in a Patient With Recurrent Biparental Complete Hydatidiform Mole: A Brief Report.
Hemida R; van Doorn H; Fisher R
Int J Gynecol Cancer; 2016 Sep; 26(7):1351-3. PubMed ID: 27465884
[TBL] [Abstract][Full Text] [Related]
64. Genetic mapping of a maternal locus responsible for familial hydatidiform moles.
Moglabey YB; Kircheisen R; Seoud M; El Mogharbel N; Van den Veyver I; Slim R
Hum Mol Genet; 1999 Apr; 8(4):667-71. PubMed ID: 10072436
[TBL] [Abstract][Full Text] [Related]
65. COVID-19 and hydatidiform mole.
Abbas AM; Ahmed L; Salem AS; Elsamman SH; Refai A; Fathy SK; Ahmed OA; Shalotut AS; AbdelWahab RA
Am J Reprod Immunol; 2020 Nov; 84(5):e13310. PubMed ID: 32698238
[TBL] [Abstract][Full Text] [Related]
66. High Risk of Gestational Trophoblastic Neoplasia Development in Recurrent Hydatidiform Moles with
Kocabey M; Gulhan I; Koc A; Cankaya T; Karatasli V; Ileri A
Balkan J Med Genet; 2023 May; 25(2):45-50. PubMed ID: 37265977
[TBL] [Abstract][Full Text] [Related]
67. No evidence for mutations in NLRP7, NLRP2 or KHDC3L in women with unexplained recurrent pregnancy loss or infertility.
Aghajanova L; Mahadevan S; Altmäe S; Stavreus-Evers A; Regan L; Sebire N; Dixon P; Fisher RA; Van den Veyver IB
Hum Reprod; 2015 Jan; 30(1):232-8. PubMed ID: 25376457
[TBL] [Abstract][Full Text] [Related]
68. Paternal Hemizygosity in 11p15 in Mole-like Conceptuses: Two Case Reports.
Sunde L; Lund H; J Sebire N; Grove A; Fisher RA; Niemann I; Kjeldsen E; Andreasen L; Hansen ES; Bojesen A; Bolund L; Nyegaard M
Medicine (Baltimore); 2015 Nov; 94(44):e1776. PubMed ID: 26554776
[TBL] [Abstract][Full Text] [Related]
69. NLRP7: From inflammasome regulation to human disease.
Carriere J; Dorfleutner A; Stehlik C
Immunology; 2021 Aug; 163(4):363-376. PubMed ID: 34021586
[TBL] [Abstract][Full Text] [Related]
70. The genetics of hydatidiform moles: new lights on an ancient disease.
Slim R; Mehio A
Clin Genet; 2007 Jan; 71(1):25-34. PubMed ID: 17204043
[TBL] [Abstract][Full Text] [Related]
71. Novo pathogenic variations of NLRP7 increasing the risk of gestational trophoblastic neoplasia.
Tao C; Zhu T; Tang S; Lu J; Lin X; Li X; Liu X; Pang Y; Zhao H; Liang J; Zhang F; Lu X; Zhang L
Clin Genet; 2023 Apr; 103(4):498-500. PubMed ID: 36544392
[TBL] [Abstract][Full Text] [Related]
72. A genetic association study of NLRP2 and NLRP7 genes in idiopathic recurrent miscarriage.
Huang JY; Su M; Lin SH; Kuo PL
Hum Reprod; 2013 Apr; 28(4):1127-34. PubMed ID: 23360675
[TBL] [Abstract][Full Text] [Related]
73. Genetics and Epigenetics of Recurrent Hydatidiform Moles: Basic Science and Genetic Counselling.
Nguyen NM; Slim R
Curr Obstet Gynecol Rep; 2014; 3(1):55-64. PubMed ID: 24533231
[TBL] [Abstract][Full Text] [Related]
74. Mutations causing familial biparental hydatidiform mole implicate c6orf221 as a possible regulator of genomic imprinting in the human oocyte.
Parry DA; Logan CV; Hayward BE; Shires M; Landolsi H; Diggle C; Carr I; Rittore C; Touitou I; Philibert L; Fisher RA; Fallahian M; Huntriss JD; Picton HM; Malik S; Taylor GR; Johnson CA; Bonthron DT; Sheridan EG
Am J Hum Genet; 2011 Sep; 89(3):451-8. PubMed ID: 21885028
[TBL] [Abstract][Full Text] [Related]
75. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2--Genetics.
Fisher RA; Paradinas FJ; Soteriou BA; Foskett M; Newlands ES
J Pathol; 1997 Feb; 181(2):189-95. PubMed ID: 9120724
[TBL] [Abstract][Full Text] [Related]
76. A familial case of recurrent hydatidiform molar pregnancies with biparental genomic contribution.
Helwani MN; Seoud M; Zahed L; Zaatari G; Khalil A; Slim R
Hum Genet; 1999; 105(1-2):112-5. PubMed ID: 10480363
[TBL] [Abstract][Full Text] [Related]
77. The genomic architecture of NLRP7 is Alu rich and predisposes to disease-associated large deletions.
Reddy R; Nguyen NM; Sarrabay G; Rezaei M; Rivas MC; Kavasoglu A; Berkil H; Elshafey A; Abdalla E; Nunez KP; Dreyfus H; Philippe M; Hadipour Z; Durmaz A; Eaton EE; Schubert B; Ulker V; Hadipour F; Ahmadpour F; Touitou I; Fardaei M; Slim R
Eur J Hum Genet; 2016 Oct; 24(10):1445-52. PubMed ID: 26956250
[TBL] [Abstract][Full Text] [Related]
78. NLRP7 and the Genetics of Hydatidiform Moles: Recent Advances and New Challenges.
Slim R; Wallace EP
Front Immunol; 2013; 4():242. PubMed ID: 23970884
[TBL] [Abstract][Full Text] [Related]
79. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation].
Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087
[TBL] [Abstract][Full Text] [Related]
80. Hydatidiform Mole-Between Chromosomal Abnormality, Uniparental Disomy and Monogenic Variants: A Narrative Review.
Florea A; Caba L; Grigore AM; Antoci LM; Grigore M; Gramescu MI; Gorduza EV
Life (Basel); 2023 Dec; 13(12):. PubMed ID: 38137915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
